Find all companies researching cancer treatment

Intellia Therapeutics is involved in medical research and is specifically working on cancer treatment through collaborations to advance allogeneic CRISPR-edited NK cell therapies and T cell-based cancer therapies.

FogPharma is involved in medical research and has multiple programs specifically targeting cancer treatment, including therapies for prostate cancer, tumors with Cyclin E1/2 amplification, and RAS family oncogenes. Additionally, they are developing Helicon-enabled alpha radioligand therapies for cancer treatment.

Orion Biotechnology is involved in medical research and has multiple projects focused on cancer treatment, including 'CCR5 Immunotherapy for Advanced Cancer' and the CXCR6 discovery campaign for solid tumor cancers.

Fate Therapeutics is involved in medical research and is specifically focused on cancer treatment. The company is developing a pipeline of iPSC-derived NK cell product candidates for the treatment of cancer and is collaborating with multiple institutions on cancer immunotherapies.

Accent Therapeutics is involved in medical research and their research is specifically focused on cancer treatment. They develop small molecule therapeutics targeting RNA-modifying proteins for cancer treatment and have multiple programs designed to address significant unmet medical needs in cancer therapy.

LEAH Labs is involved in medical research, specifically developing CAR-T cell therapy for pets with cancer, which is a treatment also used for humans. This indicates a focus on cancer treatment.

Kent Hospital is involved in medical research and has a dedicated cancer program offering a comprehensive range of services. It participates in clinical research trials through the Cancer Registry and offers a variety of oncology trials through the Cancer Trials Support Unit (CTSU).

IDEAYA Biosciences is a clinical-stage precision medicine oncology company focusing on the discovery and development of targeted therapeutics for genetically-defined cancers. The company is actively pursuing the discovery and development of precision medicine therapeutics for oncogenic and synthetic lethality targets in solid tumors, and has established a strategic research collaboration with Cancer Research UK related to its PARG program.

MEI Pharma is involved in medical research specifically focused on developing cancer therapies, including treatments for hematologic malignancies and solid tumors.